GO From the Editor's Desk
FDA Unveils Plan To Regulate Drug Compounding Pharmacies
DIA and Rare Disease Patient Community
USA Today (12/2, Healy)
Reuters (12/3, Berkrot)
The Hill (12/3, Hattem)
Boston Globe (12/3, Lazar)
Detroit Free Press (12/3, Spangler)
CQ (12/3, Ethridge)
MedPage Today (12/3)
Modern Healthcare (12/2)
Our DIA 2013 49th Annual Meeting featured two documentaries on rare disease patients and the rare disease community. The documentary Here. Us. Now. - A Family's Fight to Bring Medical Innovation Home told the story of Chris and Hugh Hempel, whose twin daughters Addison and Cassidy are in the fight of their lives with Niemann-Pick Type C, a rare and incurable genetic disease that causes progressive neurological deterioration. DIA's Regulatory Affairs Community previously helped the Hempels with regulatory and protocol development, which was spotlighted in our June 2010 Global Forum (Vol. 2, Iss. 3). The Hempel's story has since been picked up by The Wall Street Journal series TRIALS: A Fight for Children with Niemann-Pick Type C, a Fatal Genetic Disease.
PSURS and PBRERS Assessed after First Year
Read about the changes to the EU legislation in 2012 and how effectively the changes have been implemented.
Steven P Spielberg MD, PhD Discusses the Evolution of Therapeutic Interventions that have Stemmed from the AIDS Epidemic
Read More | More Information
View Archived News.
October Global Forum Now Online: This issue's Special Section explores Clinical Drug Development in Older Patients, an Increasingly Important 'Special Population.' It reviews the evolution of pertinent regulatory guidance in the EU and US, the practical aspects of conducting studies with and collecting data from elderly patients, and related topics. Also Features: A profile of new DIA Global Chief Executive Barbara Lopez Kunz, a detailed report from our DIA 2013 49th Annual Meeting CDER Town Hall and our 26th Annual EuroMeeting preview.
Read the October issue.
DIA Names Barbara Lopez Kunz Global Chief Executive
Worldwide Life Sciences Business Leader to Bring New Vision and Momentum to DIA
In the News: USAe announces Barbara Lopez as Global Chief Executive
Editor-in-Chief's Commentary: Therapeutic Innovation & Regulatory Science | November 2013
Read full commentary.
New! Content Currents
DIA's Content Currents provides important new global regulatory developments and their impact on pharmaceutical, biotechnology, and medical product development.
Read current issue.
What Lies Ahead for 2013?
DIA's first annual What Lies Ahead? report, provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.
This edition of Insider Update provides insights from key thought leaders about the marketing and promotion of pharmaceuticals, over-the-counter (OTC) drugs, biologics, and medical devices.
TIRS Podcasts Online!
The first podcast from Therapeutic Innovation & Regulatory Science (TIRS) has been posted on the journal’s homepage. Based on the special section Maternal and Child Health Therapeutics in the September 2013 TIRS (Vol. 47, Iss. 5), Editor in Chief Dr. Stephen Spielberg and Dr. Lode DeWulf discuss the urgent need for better data to guide clinical decision making during pregnancy. Access this podcast by clicking the “Podcasts” button beneath “Editor’s Choice Collection,” which links you to the download.
Podcasts are complimentary to all site visitors, so please share this link with your professional network. TIRS will host a podcast each month, using a published journal article as a foundation, on a topic of interest.
Today's Top Story
In his article, EURO EXCHANGE, author Graham Hughes discusses this year’s 25th annual DIA Euromeeting in Amsterdam and reflects on his 15 years of attending DIA events.
GO DIA 2014 50th Annual Meeting
DIA 2014 50th Annual Meeting: Celebrate the Past - Invent the Future
June 15-19 | San Diego, CA
This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients. With this year’s theme, Celebrate the Past - Invent the Future, we will be doing just that and DIA invites YOU to join us in San Diego. Register Early to Save!
The DIA Annual Meeting is the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.
Schedule At-A-Glance | Overview | Register Now | Justification Letter
View the Continuing Education credits that are available.
GO Meetings & Training
See What’s Happening this Fall in North America
DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations. Professional development options include:
Conferences & Meetings | In-Person Training | In-company Training |Online Learning | Certificate Programs
Pictures from the 2013 US Conference on Rare Diseases and Orphan Products: New Era in Healthcare
Conference held October 7-9, 2013 at the Bethesda North Marriott Hotel and Conference Center in North Bethesda, MD. This conference was sponsored by NORD and DIA (the Drug Information Association).
Upcoming educational opportunities in your region:
GO Member Benefits
New! Free access to one of DIA's archived webinars featuring up-to-the-minute information about the latest developments in the medical product industry
Just added! The Impact of Drug Shortages on the Pharmaceutical Industry
More than 18,000 members worldwide look to DIA as the only global, neutral, nonprofit, multidisciplinary association to address the challenges you face every day. Take advantage of all the benefits of membership, including:
DIA ConneX is a trusted, interactive, web-based network that links DIA’s 18,000-member global community. DIA members use ConneX to collaborate, communicate, network, and exchange information. Through ConneX, DIA members:
- Share documents
- Engage in online discussions
- Post community event information
- Make announcements and post news
- Join Communities (formerly SIACs)
GO Exhibiting & Advertising
Showcase your company's products or services to key decision-makers from across the pharmaceutical, biotechnology, medical device, and related fields.
Contract Service Organization (CSO) Directory
Reserve your spot in our exclusive print and online partner directory featuring full-page descriptions and contact information for yours and other clinical trial and medical product development service companies around the world.
View partner listings.
Join DIA and an anticipated 450+ companies with a booth at the DIA 2013 49th Annual Meeting!
Upcoming exhibiting opportunities in your region:
Advertise your company's products and services to professionals from the pharmaceutical, biotechnology, medical device, and related sectors.
Place your advertising message in front of more than 18,000 professionals involved in every aspect of medical product discovery, development, and delivery.
GO Communities Showcase
New Era for Communities
DIA is a global member association that provides knowledge resources across the full spectrum of medical product development. In the last few years the organization has expanded that global reach and will continue to grow to meet the need for health care knowledge exchange around the world.
As DIA’s reach expands globally we believe a name change is necessary. Our global volunteers came to consensus on "Community" to replace "SIACs." This change will enhance the visibility of the groups and make it much easier to recognize their purpose.
Each Community is led by a chairperson who is responsible for the overall activities of the Community. View complete list of Community chairpersons.
GO Student Initiatives
DIA offers students many opportunities to get involved and contribute in a collegial, inclusive, collaborative, positive, respectful, and professional environment in support of DIA’s mission. available student opportunities include:
- Student Volunteer Program
- Young Professionals Fellowship Program
- Student Fellowship Program
- Complimentary EuroMeeting registration
- Student Poster Session (North America, Europe, China Annual Meetings)
- Discount registration (North America and Europe Annual Meetings)
- Group Discounts for DIA Student Chapter members
- Student Membership
- Student Engagement at DIA Annual Meeting
- Student Chapters
Medical Students Remain Unfazed by Professors Industry Relationships
Medical Genetics Residency Programs: Medical Genetics is Transforming Medicine
GO Patient Initiatives
Through DIA’s worldwide conferences and programs, patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices.
Help Reduce Your Risk of Birth Defects
Watch this video from the National Birth Defects Prevention Network (NBDPN), a volunteer-based organization that addresses the issues of birth defects surveillance, research and prevention under one umbrella by maintaining a national network of state and population-based birth defects programs.
Article of Interest: Donna Mayer on DIA Patient Advocacy
Patient organizations play a key role in the DIA 2013 49th Annual Meeting Program. Patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices. DIA is working to ensure that the "voice of the patient' is heard globally in every facet of the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products.
DIA and NORD invite patient organizations and patients to attend the US Conference on Rare Diseases and Orphan Products to network with other stakeholders in the rare diseases community.